MA H1313

Prohibits health insurers from requiring patients to use insurer-selected pharmacies for clinician-administered drugs (injectable/infusible medications given in medical settings)

Bars insurers from imposing higher copays, coinsurance, or additional fees when patients obtain clinician-administered drugs from their chosen provider or pharmacy

Prevents insurers from steering patients through financial incentives or refusing to pay providers who obtain medications from non-network pharmacies

Prohibits requiring specialty pharmacies to dispense medications directly to patients for transport to healthcare providers

Allows but does not mandate insurers to offer home infusion pharmacy services or external infusion sites as alternatives